Search research articles
Contact Us
Filters
Showing results (881-890 of 901) with videos related to
Page
of 91
Sort By:
The Lancet. Respiratory Medicine
|
December 16, 2018
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
Nick Shrine, Michael A Portelli, Catherine John, et al.
The Journal of Allergy and Clinical Immunology
|
May 23, 2020
Phenotypic and functional translation of IL33 genetics in asthma
Maria E Ketelaar, Michael A Portelli, F Nicole Dijk, et al.
JCI Insight
|
April 24, 2020
Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium
Michael A Portelli, F Nicole Dijk, Maria E Ketelaar, et al.
The Journal of Infection
|
October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study
Florencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Physical Review Letters
|
September 22, 2023
Search for a Dark-Matter-Induced Cosmic Axion Background with ADMX
T Nitta, T Braine, N Du, et al.
Physical Review Letters
|
January 14, 2022
Search for Invisible Axion Dark Matter in the 3.3-4.2 μeV Mass Range
C Bartram, T Braine, E Burns, et al.
The Review of Scientific Instruments
|
December 11, 2023
Dark matter axion search using a Josephson Traveling wave parametric amplifier
C Bartram, T Braine, R Cervantes, et al.
Nature Microbiology
|
December 22, 2020
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland
Ana da Silva Filipe, James G Shepherd, Thomas Williams, et al.
The Journal of Infection
|
August 9, 2025
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial
Leila Janani, Alasdair P S Munro, Annie Wright, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
Page
of 91
Search research articles
Search
Showing results (881-890 of 901) with videos related to
Sort By:
Page
of 91
The Lancet. Respiratory Medicine
|
December 16, 2018
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
Nick Shrine, Michael A Portelli, Catherine John, et al.
The Journal of Allergy and Clinical Immunology
|
May 23, 2020
Phenotypic and functional translation of IL33 genetics in asthma
Maria E Ketelaar, Michael A Portelli, F Nicole Dijk, et al.
JCI Insight
|
April 24, 2020
Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium
Michael A Portelli, F Nicole Dijk, Maria E Ketelaar, et al.
The Journal of Infection
|
October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study
Florencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Physical Review Letters
|
September 22, 2023
Search for a Dark-Matter-Induced Cosmic Axion Background with ADMX
T Nitta, T Braine, N Du, et al.
Physical Review Letters
|
January 14, 2022
Search for Invisible Axion Dark Matter in the 3.3-4.2 μeV Mass Range
C Bartram, T Braine, E Burns, et al.
The Review of Scientific Instruments
|
December 11, 2023
Dark matter axion search using a Josephson Traveling wave parametric amplifier
C Bartram, T Braine, R Cervantes, et al.
Nature Microbiology
|
December 22, 2020
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland
Ana da Silva Filipe, James G Shepherd, Thomas Williams, et al.
The Journal of Infection
|
August 9, 2025
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial
Leila Janani, Alasdair P S Munro, Annie Wright, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
Page
of 91